The future of bone marrow stromal cell transplantation for the treatment of spinal cord injury

查看全文 作　　者：Mitsuhiro [1,2]Enomoto

机构地区：[1]Department of Orthopaedic and Spinal Surgery,Graduate School,Tokyo Medical and Dental University;[2]Hyperbaric Medical Center,Tokyo Medical and Dental University

出　　处：《Neural Regeneration Research》索引2015年第10卷第3期,共2页

基　　金：supported in part by the Ministry of Health,Labour and Welfare Sciences Research Grant;a Grant-in-Aid for Scientific Research(C)from the Japan Society for the Promotion of Science;a Grant-in-Aid from the General Insurance Association of Japan 摘　　要：Bone marrow stromal cell(BMSC)transplantation therapy is a promising approach for treating spinal cord injury(SCI),based on a number of experimental and clinical reports(Wright et al.,2011).BMSCs are a source of neuroregenerative somatic stem cells that are without the potential for tumorigenicity.Although clinical studies of autologous BMSC transplantation have been reported in 关键词：骨髓基质干细胞移植治疗脊髓损伤骨髓基质细胞 BMSC 临床报告神经再生 SCI

相关文献

参考文献（12）
引证文献（6）
耦合文献（0）

参考文献(12)

引证文献(6)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

The future of bone marrow stromal cell transplantation for the treatment of spinal cord injury

参考文献(12)

引证文献(6)

用户提示